<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g227" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-225.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-224.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-225.html" >Gonococcal Infections</a><span class="carrot"> > </span>
                    <a href="lv-225.html" >Gonococcal Infections in Adolescents and Adults</a><span class="carrot"> > </span>Dual Therapy for Gonococcal and Chlamydial Infections
            </div>
            </br><h3 class="sgc-2" id="sigil_toc_id_227">
 Dual Therapy for Gonococcal and Chlamydial Infections
</h3>
<p>
 Patients infected with
 <i>
  N. gonorrhoeae
 </i>
 frequently are coinfected with
 <i>
  C. trachomatis
 </i>
 ; this finding has led to the recommendation that patients treated for gonococcal infection also be treated routinely with a regimen that is effective against uncomplicated genital
 <i>
  C. trachomatis
 </i>
 infection (294). Because most gonococci in the United States are susceptible to doxycycline and azithromycin, routine cotreatment might also hinder the development of antimicrobial-resistant
 <i>
  N. gonorrhoeae
 </i>
 . Limited data suggest that dual treatment with azithromycin might enhance treatment efficacy for pharyngeal infection when using oral cephalosporins (295,296).
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

